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deciding on a single-stage or two-stage exchange arthroplasty in patients with chronic PJI. However, PJI in the shoulder often presents a diagnostic challenge due to the indolent nature of the common infecting organisms, including Propionibacterium acnes (P. acnes) 7 and the lower efficacy of common diagnostic markers relative to those for periprosthetic hip and knee infections. The sensitivities of the serum erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) level in the diagnosis of PJI in the shoulder have been reported to be 16% and 42%, respectively 8 , compared with 95% and 88% for the diagnosis of hip PJI and 94% and 97% for the diagnosis of knee PJI 9 . As a result, it is common for a one-stage exchange to be performed because perioperative markers of infection were negative at the time of the revision surgery, only to be followed by an unexpected positive result of intraoperative cultures after the surgery.
Newer tests for the diagnosis of PJI have recently been studied and may be more efficacious for the shoulder. In particular, the measurement of pro-inflammatory cytokine interleukin-6 (IL-6) levels may hold promise, with multiple studies showing both synovial fluid 10 and serum 11, 12 levels to have sensitivities and specificities of >95% in the diagnosis of hip and knee PJI. Although one small study showed a benefit of measuring serum IL-6 levels in the shoulder 13 , subsequent studies examining primarily indolent infections have shown analysis of serum IL-6 levels to have poor sensitivity and minimum diagnostic value in the diagnosis of PJI of the shoulder 14, 15 . We are not aware of any studies evaluating the efficacy of synovial fluid IL-6 analysis for diagnosis of PJI of the shoulder. Therefore, the goal of this study was to evaluate the diagnostic utility of synovial fluid IL-6 analysis for patients undergoing revision shoulder arthroplasty.
Materials and Methods

Patient Selection
O ur institutional review board approved this study, and informed consent was obtained from all patients. All patients, treated by two shoulder surgeons (J.P.I. and E.T.R.), who were evaluated for pain at the site of a shoulder arthroplasty were prospectively enrolled from November 2012 to September 2013. Forty-six consecutive patients were enrolled in the study. All underwent a preoperative routine workup for PJI, including measurements of the serum ESR and CRP level as well as shoulder aspiration for synovial fluid culture and IL-6 analysis. Patients who did not subsequently undergo revision shoulder arthroplasty because there was not a clear indication for surgical intervention, because their pain resolved, or because they preferred a nonoperative approach (n = 11) were excluded, as intraoperative tissue specimens for cultures and frozen-section histologic analysis were required for the diagnosis of PJI. The median synovial fluid IL-6 level in these excluded patients was 305 pg/mL (interquartile range, 81 to 460 pg/mL), with four having an elevated level. Three of the forty-six patients had a dry arthrocentesis and synovial fluid could not be obtained either intraoperatively or preoperatively for IL-6 analysis; they were therefore excluded as well. There were no differences in clinical or laboratory parameters between these fourteen excluded patients and the included cohort. Thirty-two patients underwent revision shoulder arthroplasty, during which synovial fluid was obtained, and synovial fluid was also obtained preoperatively for IL-6 analysis for nine of them (Fig. 1) . Samples from thirty-five procedures were analyzed as three patients had samples obtained both at the time of their initial revision surgery and at the second-stage reimplantation. All IL-6 synovial 
fluid analysis was performed in a delayed manner with use of the research protocol described below. Therefore, these data were not available for clinical decision-making either preoperatively or intraoperatively and were analyzed strictly for the purposes of this study. At the time of the revision surgery, prior to arthrotomy, synovial fluid was obtained for culture and IL-6 analysis via direct needle aspiration to mimic preoperative conditions and to avoid contamination with blood. Multiple periprosthetic tissue specimens were also obtained intraoperatively from all patients (mean, four cultures; standard deviation [SD], 1.5; range, two to seven). These included samples along the glenoid and/or humeral components, intramedullary tissue if a humeral stem was removed, tissue off the glenoid osseous surface and glenoid holes if a glenoid component was removed, and deep capsular tissue or pseudocapsular tissue in a cuff-deficient revision. Fluid and tissue specimens were processed according to standard laboratory protocol with cultures maintained for fourteen days (see Appendix). Intraoperative tissue specimens also underwent frozen-section histologic analysis, with five or more polymorphonuclear leukocytes in each of three or more high-power (·400) fields used as the institutional criterion for acute inflammation consistent with infection. Basic demographic and perioperative characteristics of the revision surgery cohort are shown in Table I . Patients undergoing singlestage exchange had revision of the humeral and/or glenoid components, with the decision to use a standard or reverse prosthesis based on the amount of bone loss and rotator cuff deficiency. Two-stage exchange included removal of all components and placement of an antibiotic spacer during the first stage, and reimplantation of a standard or reverse prosthesis at the second surgery based on the amount of bone loss and rotator cuff deficiency.
To obtain baseline data for non-arthritic shoulders, we measured synovial fluid IL-6 levels in twenty patients undergoing primary arthroscopic rotator cuff repair who had no evidence of arthritic changes. Samples from primary arthroplasties were not used for controls because of inconsistency in the literature describing IL-6 levels in patients with osteoarthritis 16, 17 . Rotator cuff tears were chosen as a condition not caused by infection and in which adequate intraoperative synovial fluid samples could be obtained for analysis. Thirty consecutive patients undergoing arthroscopic rotator cuff repair had been enrolled in the study to obtain synovial fluid IL-6 levels, but no fluid could be obtained from ten of them (Fig. 1 ).
Synovial Fluid Handling and IL-6 Testing
For IL-6 testing, synovial fluid samples were centrifuged at 2000 rpm for ten minutes, within two hours after collection, to remove all cellular and particulate content. The resulting supernatant was divided into aliquots and stored in a 270°C freezer until samples were sent for testing. IL-6 levels in synovial fluid were measured with use of the Human Proinflammatory Ultra-Sensitive Kit on the Meso Scale Discovery (MSD) MULTI-ARRAY platform (Rockville, Maryland) (see Appendix).
Infection Criteria
There is no gold standard to establish or rule out the diagnosis of infection at the site of a shoulder arthroplasty. There is controversy even when intraoperative cultures are positive because of the difficulty in distinguishing true infection from contamination, especially with less virulent organisms such as P. acnes. Therefore, we used a spectrum of infection categories based on objective clinical, laboratory, and histologic criteria, including serum ESR and CRP level, frozensection histologic analysis, and results of cultures of preoperative synovial fluid aspirate and intraoperative tissue and synovial fluid specimens (Table II) . These criteria were consistent with those described in the current literature 3, [18] [19] [20] . To facilitate the analysis of the diagnostic utility of synovial fluid IL-6 results, the subcategories were condensed into two groups: a no-infection group and an infection group. The no-infection group included patients treated with revision who met the criteria for the probable-contamination category or no evidence of infection (Table II) and control patients who underwent arthroscopic rotator cuff repair. The infection group included patients who met the criteria for definite infection or probable infection (Table II) . Most of the literature defines patients who meet the criteria for our probable-contamination group as not infected, which is why these patients were included in the no-infection group 3, 21, 22 . The diagnosis category for all patients was established by authors (J.P.I., E.T.R., T.W.B., S.J.F., and M.J.G.) blinded to the IL-6 values.
Data Analysis
The ability of synovial fluid IL-6 analysis to predict infection status was explored by using receiver operating characteristic curves. Youden's criterion was used to choose an ideal cutoff point for determining infection status on the basis of the IL-6 level. According to this criterion, the point on the receiver operating characteristic curve that maximizes the sum of sensitivity and specificity is considered to be the ideal cutoff level. The efficacy of using IL-6 analysis to predict infection status was described by using the area under the curve, sensitivity, specificity, and positive and negative likelihood ratios. Relationships between intraoperative synovial fluid IL-6 values and other objective variables were also analyzed, with significance set at p < 0.05 (see Appendix).
Source of Funding
This study was funded by the Orthopaedic Operating Room of the Future Grant in the Orthopaedic and Rheumatologic Institute at the Cleveland Clinic.
Results
O
f the thirty-five revision shoulder arthroplasties, fifteen (43%) met the criteria for the infection group (ten probable infection and five definite infection). The no-infection group, therefore, included twenty revision shoulder arthroplasties (one probable contamination and nineteen no evidence of infection) and twenty arthroscopic rotator cuff repairs. Synovial fluid IL-6 analysis demonstrated high diagnostic accuracy for PJI with an area under the curve of 0.891 and an ideal cutoff value (determined with use of Youden's criterion) of 359.3 pg/mL (Fig. 2) . Synovial fluid IL-6 analysis had high sensitivity and specificity (87% and 90%, respectively), with positive and negative likelihood ratios of 8.45 and 0.15, respectively. A positive likelihood ratio of 8.45 indicates that a positive IL-6 value increases the pretest odds of infection by a factor of 8.5. Similarly, a negative likelihood ratio of 0.15 indicates that a negative IL-6 value decreases the pretest odds of infection by a factor of 0.15. When applying the Musculoskeletal Infection Society (MSIS) definition for PJI instead of our proposed criteria, the area under the curve was 0.892 and the ideal cutoff for IL-6 was 446 pg/mL. The sensitivity, specificity, and positive and negative likelihood ratios were 86%, 95%, 17.2, and 0.15, respectively.
With use of the cutoff value of 359.3 pg/mL for the diagnosis, synovial fluid IL-6 analysis resulted in four false-positive and two false-negative results (Fig. 3) . Of the four false-positive results, two were for patients who underwent arthroscopic rotator cuff repair, one was for a sample obtained during a Receiver operating characteristic curve for prediction of periprosthetic shoulder infection based on IL-6 levels. AUC = area under the curve. 
second-stage reimplantation that was done within four weeks after the first-stage procedure, and one was for a case classified as probable contamination with only one positive intraoperative culture (for Staphylococcus epidermidis). Both patients with a false-negative result had had multiple operations prior to their revision and had cultures that were positive for P. acnes. They were treated with one-stage revision and started on intravenous (IV) antibiotics when the cultures returned positive. Seven patients who underwent single-stage revision after standard negative perioperative tests subsequently had multiple positive intraoperative tissue cultures. The average IL-6 level in this group was 1400 pg/mL, and the IL-6 level was considered elevated in five of the seven patients. These five patients had been followed for one year or less (average, 7.4 months) at the time of this study. All five patients were treated with IV antibiotics postoperatively (average of 4.5 weeks), with four continuing with a period of oral antibiotic therapy (average, twelve weeks). Two of the five patients were doing well when last seen, at four and six months, respectively. The other three patients remained on chronic oral antibiotics, with persistent pain and stiffness in the shoulder, although levels of serum-fluid markers remained normal. Revision surgery was being considered for two of these patients-one followed for one year and the other, for seven months-because of the persistent symptoms. The two patients with negative perioperative tests and negative IL-6 values who subsequently had positive cultures were treated with IV antibiotics postoperatively (average of 5.0 weeks), without additional oral antibiotic therapy. One patient had persistent pain of unclear etiology at ten months postoperatively, and the other was doing well at one year postoperatively.
Both preoperative and intraoperative synovial fluid IL-6 levels were available for nine patients. IL-6 levels measured in synovial fluid obtained intraoperatively demonstrated a moderate correlation with those in samples obtained from the same patients preoperatively (Kendall correlation coefficient, 0.61; p = 0.025) (Table III) . However, only one of the nine patients had conflicting preoperative and intraoperative IL-6 results with regard to whether they were positive or negative based on our cutoff value of 359.3 pg/mL. Synovial fluid IL-6 levels also correlated both with the number of positive intraoperative cultures (correlation coefficient, 0.58; p < 0.001) and the percentage of positive cultures based on the total number of cultures obtained per case (correlation coefficient, 0.52; p < 0.001), but they demonstrated a weak correlation with serum CRP levels and no correlation with serum ESR (Table III) 
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Synovial fluid IL-6 levels also showed strong associations with findings on frozen-section histologic analysis and growth of P. acnes on culture (Table IV) . The median IL-6 value in patients with positive frozen sections was 24,621 pg/mL compared with 192 pg/mL in patients with negative frozen sections (p < 0.001). Synovial fluid IL-6 levels were also elevated in the presence of a P. acnes-positive culture (median, 8531 pg/mL). Of the seven patients with positive intraoperative cultures for P. acnes, four had frozen-section results that met the criteria for acute inflammation. Patients who met the criteria for probable infection (one positive culture and other signs of infection, or no signs of infection but more than one positive culture) had higher IL-6 values than patients in the no-infection group (median, 1400 versus 93 pg/mL; p < 0.001). Within the no-infection group, synovial fluid IL-6 levels did not differ significantly between the patients who underwent revision shoulder arthroplasty and those treated with arthroscopic rotator cuff repair (p = 0.1; Table IV) .
Discussion P JI is a major complication after shoulder arthroplasty and remains a diagnostic challenge because of the subtle, often nonspecific clinical presentation of indolent organisms such as P. acnes. Early and successful identification of infection is critical for determining subsequent medical and surgical management, but current perioperative testing has been shown to be ineffective in diagnosis. The aim of this study was to define the diagnostic utility of synovial fluid IL-6 levels as a potential marker for PJI of the shoulder. To our knowledge, this is the first study in the literature to evaluate synovial fluid IL-6 as a marker of infection after shoulder arthroplasty. Our results suggest that synovial fluid IL-6 analysis is both sensitive and specific for predicting the presence of PJI in patients undergoing revision shoulder arthroplasty.
Recent efforts to identify more accurate markers of PJI have targeted synovial fluid. Because serum markers may be confounded by a concomitant acute or chronic inflammatory state, assessments of local markers in the affected joints may be better diagnostic tests. Deirmengian et al. identified several synovial fluid biomarkers, including IL-6, whose levels were substantially elevated in patients with hip or knee PJI 10 . In their study, synovial fluid IL-6 analysis had a sensitivity and specificity of 100% at a cutoff value of 13,350 pg/mL. Similarly, in a study of several biomarkers, Jacovides et al. found synovial fluid IL-6 levels to be most strongly linked to hip and knee PJI, with 87% sensitivity, and 100% specificity 22 . More recently, Gollwitzer et al. assessed the diagnostic efficacy of synovial fluid IL-6 analysis in identifying staphylococcal hip and knee PJI using cytometric bead arrays 23 . They reported an area under the curve of 0.807, a sensitivity of 60%, and a specificity of 95% using a cutoff value of 1896.6 pg/mL. Because of differences in the bioassays and in the infecting organisms, it is difficult to compare our data with the previously reported hip and knee literature. However, using a cutoff of 359 pg/mL, we showed a sensitivity (87%) and specificity (90%) similar to those in previously reported studies. It must be noted that the high positive likelihood ratio of 8.45 should be interpreted as an increase in the pretest odds of having an infection rather than the risk of having an infection. This distinction is particularly important for patients with a high probability of having an infection, such as those presenting with pain at the site of a shoulder arthroplasty. For these patients, the odds tend to overestimate the risk.
The findings of this study demonstrate the clinical utility and relevance of incorporating synovial fluid IL-6 analysis in the diagnostic workup for patients undergoing revision shoulder arthroplasty. When synovial fluid can be obtained, we recommend the use of an IL-6 assay as part of the preoperative evaluation. Eight of the nine patients from whom both preoperative and intraoperative samples were obtained had agreement between the IL-6 results of the two assays. Ten patients who had negative ESR and CRP values had two or more positive intraoperative cultures (probable-infection subgroup) and were treated postoperatively with intravenous antibiotics. Only three of these ten patients underwent a two-stage procedure, which is the standard treatment when PJI is identified preoperatively or intraoperatively. Of the remaining seven patients, who underwent a single-stage revision, five had intraoperative synovial fluid IL-6 levels that were considered elevated. Also, the overall median value was 1400.2 pg/mL in the probable-infection subgroup compared with 93.3 pg/mL in the no-infection group (p < 0.001) (Table IV) . If the IL-6 data had been available preoperatively or intraoperatively for the five patients who had a singlestage revision and subsequently had positive cultures, a two-stage exchange might have been chosen instead. This is important particularly in light of the postoperative finding that three of the five patients continued to have shoulder pain and stiffness with persistent infection a potential concern. This not only demonstrates the potential efficacy of synovial fluid IL-6 analysis, but also reiterates the insufficiency of the current diagnostic modalities. Furthermore, synovial fluid IL-6 levels were significantly higher in patients who had growth of P. acnes on culture (median, 8531 pg/mL) than in patients for whom cultures were negative for infection (median,123.4 pg/mL, p = 0.011), indicating the potential to better detect infections caused by indolent infecting organisms preoperatively or intraoperatively.
While the correlation between preoperative and intraoperative synovial fluid IL-6 values was only moderate in the nine patients who had both assays, eight of the nine had preoperative and intraoperative samples that were consistent in terms of whether they were positive or negative according to the cutoff value of 359.3 pg/mL. These are promising results in favor of using synovial fluid IL-6 analysis as a preoperative test, but it is difficult to make definitive conclusions on the basis of only nine cases. The poor correlation of synovial fluid IL-6 analysis with serum ESR and CRP levels is consistent with the poor accuracy of the latter tests for diagnosing PJI of the shoulder 8 . The strong association between a finding of acute inflammation on frozensection histologic analysis and elevated synovial fluid IL-6 levels is reasonable considering that IL-6 is a pro-inflammatory marker.
The use of the MSD platform for synovial fluid analysis provided some distinct advantages. First, the low-end analytical sensitivity of the assay allowed detection of IL-6 in relatively small volumes of synovial fluid, which enabled testing of a high percentage of the enrolled patients. This will be an important factor in the clinical setting, in which the ability to aspirate larger volumes of synovial fluid from the shoulder can be challenging. This is particularly true in the preoperative setting, as in-office aspiration may yield scant or no fluid. In the current study, a preoperative sample was obtained from only twenty-two (48%) of the forty-six originally enrolled patients. Image-guided aspiration may be the optimal method for obtaining a preoperative sample, but the volume yield may still be low. However, demonstrating the efficacy of this biomarker is the first step in developing a point-of-care test that can provide results intraoperatively, when a synovial fluid sample is easier to obtain (a 91% success rate in the current study) and in cases in which preoperative fluid is not available. A second benefit of the MSD platform is that the plate-based nature of the technology is less prone to the matrix issues with synovial fluid that influence bead-based assays 24 . This led to a very low rate of analytical failures in our study. Finally, the wide dynamic range of the assay allowed changes of as much as 1000-fold over baseline to be readily detected with a minimum of dilutions. This should allow better differentiation of patients with elevated levels and may be helpful in following responses to treatment in future studies.
There were some limitations to the current study. First, there is no gold standard for the diagnosis of PJI following shoulder arthroplasty. Although several tests and combinations of clinical criteria have been used to classify PJI, it remains difficult to diagnose with absolute certainty. Our use of different criteria for PJI could have altered the primary results of our study, but this is an inherent limitation of any study evaluating a diagnostic test for infection. We chose to use a range of infection categories to better stratify the patient population in terms of infection odds. This allowed identification of one of the two patients with a falsenegative synovial fluid IL-6 analysis as having a probable infection. A second limitation of our study was the small sample size of patients with an infection. A large multicenter study is necessary to further characterize infected patients. Finally, indolent infections such as P. acnes tend to form biofilms and small foci surrounding the implant that could elude the scant synovial fluid that is usually present, making false-negative results an inevitable consequence of synovial fluid testing in the shoulder.
Diagnosis of infection in patients undergoing revision shoulder arthroplasty remains a diagnostic challenge due to the low virulence of the most common infecting organisms. Current guidelines for diagnosis of PJI are not sensitive for diagnosing infection in such patients. This study demonstrates the potential clinical benefit of performing synovial fluid IL-6 analysis preoperatively to detect infections at the sites of shoulder prostheses. In addition, synovial fluid IL-6 analysis may be helpful in the postoperative evaluation and treatment of cases with unanticipated positive cultures. The diagnostic accuracy of synovial fluid IL-6 analysis for identifying PJI may lead to improved decision-making regarding management of shoulder PJI, such as helping to determine the appropriate indications for one or two-stage revisions.
